We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

DAR:NYSEDarling Ingredients Inc. Analysis

Data as of 2026-03-28 - not real-time

$59.28

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Technical outlook remains bullish as the stock trades well above its 20‑day (≈55.5), 50‑day (≈50.7) and 200‑day (≈38.3) moving averages, with a bullish MACD crossover and a strong upward volume trend. However, the RSI of 73 signals an overbought condition and the price is approaching the near‑term resistance around $61.25, suggesting a potential short‑term pullback. Volatility is elevated at roughly 27% over the past 30 days, and beta below 1 indicates modest market sensitivity, but the recent rally of over 5% on high volume underscores momentum.
Fundamental and news drivers show a 20% year‑over‑year revenue growth and improving margins, with Q4 2025 results beating expectations and leverage declining quarter‑over‑quarter. Analysts rate the stock a strong buy with a median price target of $64, implying modest upside (~6%). Yet the DCF fair value of about $17 and a trailing P/E of 152 highlight significant overvaluation, while a high debt‑to‑equity ratio (≈86) and low ROE (~1.5%) raise concerns. Recent positive sentiment is tempered by a downgrade citing geopolitical headwinds, reinforcing a cautious but optimistic stance.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • RSI indicating overbought conditions
  • Price near resistance with limited upside
  • Strong recent volume but short‑term pullback risk

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Revenue growth above 20% and margin expansion
  • Analyst consensus strong‑buy with modest upside to target
  • Improving leverage and solid cash flow generation

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Significant overvaluation relative to DCF
  • High debt load and low return on equity
  • Exposure to regulatory and geopolitical risks in global operations

Key Metrics & Analysis

Financial Health

Revenue Growth20.60%
Profit Margin1.02%
P/E Ratio152.0
ROE1.52%
ROA2.50%
Debt/Equity86.53
P/B Ratio2.0
Op. Cash Flow$1.1B
Free Cash Flow$219.4M

Technical Analysis

TrendBullish
RSI73.3
Support$51.02
Resistance$61.25
MA 20$55.53
MA 50$50.72
MA 200$38.35
MACDBullish
VolumeIncreasing
Fear & Greed Index65.98

Valuation

Fair Value$16.99
Target Price$62.77
Upside/Downside5.89%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta0.92
Volatility27.16%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.